SG162798A1 - Liquid pharmaceutical formulations of docetaxel - Google Patents
Liquid pharmaceutical formulations of docetaxelInfo
- Publication number
- SG162798A1 SG162798A1 SG201004237-2A SG2010042372A SG162798A1 SG 162798 A1 SG162798 A1 SG 162798A1 SG 2010042372 A SG2010042372 A SG 2010042372A SG 162798 A1 SG162798 A1 SG 162798A1
- Authority
- SG
- Singapore
- Prior art keywords
- docetaxel
- liquid pharmaceutical
- pharmaceutical formulations
- liquid
- parenteral administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2005903196A AU2005903196A0 (en) | 2005-06-17 | Pharmaceutical formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
SG162798A1 true SG162798A1 (en) | 2010-07-29 |
Family
ID=37531888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG201004237-2A SG162798A1 (en) | 2005-06-17 | 2006-06-16 | Liquid pharmaceutical formulations of docetaxel |
Country Status (9)
Country | Link |
---|---|
US (2) | US20090118354A1 (fr) |
EP (3) | EP1904052A4 (fr) |
JP (1) | JP2008543789A (fr) |
KR (1) | KR20080030024A (fr) |
CA (1) | CA2611592A1 (fr) |
IL (1) | IL187957A0 (fr) |
SG (1) | SG162798A1 (fr) |
TW (1) | TW200800159A (fr) |
WO (1) | WO2006133510A1 (fr) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3659589A1 (fr) | 2005-08-31 | 2020-06-03 | Abraxis BioScience, LLC | Compositions comprenant des agents pharmaceutiques peu solubles dans l'eau et des agents antimicrobiens |
CA2620389C (fr) | 2005-08-31 | 2014-06-17 | Abraxis Bioscience, Llc | Compositions et methode de preparation de medicaments a faible solubilite dans l'eau presentant une stabilite accrue |
BRPI0600194A (pt) | 2006-01-30 | 2007-10-23 | Quiral Quimica Do Brasil S A | composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas |
CN101023940A (zh) * | 2006-02-20 | 2007-08-29 | 郝守祝 | 一种紫杉烷类化合物的药用组合物、制备方法及用途 |
EP1946747A1 (fr) * | 2007-01-17 | 2008-07-23 | Sandoz AG | Composition pharmaceutique à stabilité améliorée contenant des dérivés de taxane |
EP2205215A2 (fr) * | 2007-10-01 | 2010-07-14 | Intas Pharmaceuticals Limited | Composition injectable de docetaxel, étant absolument dépourvue d'éthanol |
PL2231144T3 (pl) | 2007-12-24 | 2014-12-31 | Sun Pharma Advanced Res Co Ltd | Nanodyspersja |
KR101053780B1 (ko) * | 2008-02-29 | 2011-08-02 | 동아제약주식회사 | 도세탁셀을 함유하는 단일액상의 안정한 약제학적 조성물 |
DE102008059201A1 (de) * | 2008-11-27 | 2010-06-02 | GÖPFERICH, Achim, Prof. Dr. | In situ präzipitierende Arzneistofflösungen |
MX2011013726A (es) | 2009-06-19 | 2012-02-29 | Sun Pharma Advanced Res Co Ltd | Nanodispersión de un medicamento y proceso para su preparación. |
JP5568272B2 (ja) * | 2009-09-29 | 2014-08-06 | テルモ株式会社 | ヨウ素配合脂溶性ビタミン含有液 |
US8476310B2 (en) | 2009-10-19 | 2013-07-02 | Scidose Llc | Docetaxel formulations with lipoic acid |
US8912228B2 (en) | 2009-10-19 | 2014-12-16 | Scidose Llc | Docetaxel formulations with lipoic acid |
US7772274B1 (en) * | 2009-10-19 | 2010-08-10 | Scidose, Llc | Docetaxel formulations with lipoic acid |
CN102038635A (zh) * | 2009-10-23 | 2011-05-04 | 天津天士力集团有限公司 | 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法 |
WO2011139899A2 (fr) | 2010-05-03 | 2011-11-10 | Teikoku Pharma Usa, Inc. | Formulations non aqueuses de pro-émulsions à base de taxane et procédés de fabrication et d'utilisation de ces formulations |
TWI511725B (zh) * | 2010-11-10 | 2015-12-11 | Tasly Holding Group Co Ltd | A taxane-containing drug solution containing chelating agent and a preparation method thereof |
WO2013024495A1 (fr) * | 2011-08-18 | 2013-02-21 | Dr. Reddys Laboratories Limited | Formulations pharmaceutiques de cabazitaxel |
JP2013194009A (ja) * | 2012-03-21 | 2013-09-30 | Nipro Corp | ドセタキセル製剤 |
WO2014013903A1 (fr) * | 2012-07-19 | 2014-01-23 | 富士フイルム株式会社 | Composition liquide contenant un principe actif à base de taxane, son procédé de fabrication et préparation médicinale liquide |
WO2014022237A1 (fr) | 2012-07-31 | 2014-02-06 | Yung Shin Pharm. Ind. Co., Ltd. | Cabazitaxel amorphe |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
CN103169651B (zh) * | 2012-12-26 | 2018-01-19 | 辰欣药业股份有限公司 | 一种含多西他赛的注射剂及其制备方法 |
JP6076744B2 (ja) * | 2013-01-04 | 2017-02-08 | ナガセ医薬品株式会社 | ドセタキセル含有医薬組成物 |
EP2777691A1 (fr) * | 2013-03-14 | 2014-09-17 | Pharmachemie B.V. | Taxoïde - purification des excipients liquides |
CN104546694A (zh) * | 2013-10-15 | 2015-04-29 | 悦康药业集团有限公司 | 一种多西他赛注射液及其制备方法 |
CN103626661B (zh) * | 2013-12-10 | 2015-03-18 | 重庆泰濠制药有限公司 | 一种化合物及其应用、制备方法 |
EA024176B1 (ru) * | 2014-03-05 | 2016-08-31 | Республиканское Унитарное Производственное Предприятие "Белмедпрепараты" (Руп "Белмедпрепараты") | Способ получения противоопухолевого препарата на основе доцетаксела |
US20160120742A1 (en) * | 2014-11-04 | 2016-05-05 | Sandoz Ag | Compositions including cabazitaxel |
TWI752750B (zh) | 2015-09-30 | 2022-01-11 | 香港商慧源香港創新有限公司 | 口服紫杉烷組合物及方法 |
SG11201811442UA (en) | 2016-06-20 | 2019-01-30 | Isa Pharmaceuticals B V | Formulation of a peptide vaccine |
JP6292267B2 (ja) * | 2016-09-13 | 2018-03-14 | ニプロ株式会社 | ドセタキセル製剤 |
JP7182794B2 (ja) * | 2017-08-31 | 2022-12-05 | 国立大学法人東北大学 | リンパ行性薬剤送達法に有効な薬剤を含む溶液の適正な浸透圧域 |
JP2018115178A (ja) * | 2018-03-15 | 2018-07-26 | ニプロ株式会社 | ドセタキセル製剤 |
US11439586B2 (en) | 2018-10-16 | 2022-09-13 | US Nano Food & Drug INC | Intratumour injection formulation |
KR102401546B1 (ko) * | 2020-03-25 | 2022-05-27 | 주식회사 보령 | 탁산, 이의 약학적으로 허용되는 염, 또는 그의 수화물을 함유하는 안정성이 향상된 신규 약제학적 제형 |
WO2021211294A1 (fr) | 2020-04-13 | 2021-10-21 | US Nano Food & Drug INC | Formulation d'injection intratumorale chimiothérapeutique basique |
AU2021327164A1 (en) * | 2020-08-19 | 2023-03-16 | Cellact Pharma Gmbh | Etoposide toniribate formulation |
EP4233837A1 (fr) * | 2022-02-24 | 2023-08-30 | CellAct Pharma GmbH | Compositions solides et orales de toniribate d'étoposide |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2601675B1 (fr) | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
US5698582A (en) | 1991-07-08 | 1997-12-16 | Rhone-Poulenc Rorer S.A. | Compositions containing taxane derivatives |
US5714512A (en) | 1991-07-08 | 1998-02-03 | Rhone-Poulenc Rorer, S.A. | Compositions containing taxane derivatives |
FR2678833B1 (fr) | 1991-07-08 | 1995-04-07 | Rhone Poulenc Rorer Sa | Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes. |
AU5612694A (en) * | 1992-11-27 | 1994-06-22 | Napro Biotherapeutics, Inc. | Injectable composition |
AU5553894A (en) * | 1992-11-27 | 1994-06-22 | F.H. Faulding & Co. Limited | Injectable taxol composition |
FR2698543B1 (fr) | 1992-12-02 | 1994-12-30 | Rhone Poulenc Rorer Sa | Nouvelles compositions à base de taxoides. |
AU724842B2 (en) * | 1995-12-21 | 2000-09-28 | Genelabs Technologies, Inc. | Taxane composition and method |
US5922754A (en) * | 1998-10-02 | 1999-07-13 | Abbott Laboratories | Pharmaceutical compositions containing paclitaxel |
US6040330A (en) * | 1999-01-08 | 2000-03-21 | Bionumerik Pharmaceuticals, Inc. | Pharmaceutical formulations of taxanes |
US6380405B1 (en) * | 1999-09-13 | 2002-04-30 | Nobex Corporation | Taxane prodrugs |
EP1246608A4 (fr) * | 2000-01-05 | 2005-05-18 | Imarx Therapeutics Inc | Formulations pharmaceutiques pour l'administration de medicaments ayant une faible solubilite aqueuse |
AR027714A1 (es) * | 2000-03-24 | 2003-04-09 | Baker Norton Pharma | Uso de sales metalicas para estabilizar composiciones de taxanos. |
WO2002043765A2 (fr) * | 2000-11-28 | 2002-06-06 | Transform Pharmaceuticals, Inc. | Formulations pharmaceutiques contenant du paclitaxel, ses derives et ses sels pharmaceutiquement acceptables |
EP1365759A2 (fr) * | 2001-01-18 | 2003-12-03 | PHARMACIA & UPJOHN COMPANY | Preparations de microemulsion chimiotherapeutique de paclitaxel presentant une meilleure biodisponibilite orale |
US7939098B2 (en) * | 2002-05-23 | 2011-05-10 | Femina Pharma Incorporated | Compositions and method for transmucosal drug delivery and cryoprotection |
-
2006
- 2006-06-16 EP EP06741249A patent/EP1904052A4/fr not_active Withdrawn
- 2006-06-16 KR KR1020087001355A patent/KR20080030024A/ko not_active Application Discontinuation
- 2006-06-16 WO PCT/AU2006/000843 patent/WO2006133510A1/fr active Application Filing
- 2006-06-16 EP EP09012526A patent/EP2138164A1/fr not_active Withdrawn
- 2006-06-16 US US11/922,165 patent/US20090118354A1/en not_active Abandoned
- 2006-06-16 JP JP2008516077A patent/JP2008543789A/ja active Pending
- 2006-06-16 CA CA002611592A patent/CA2611592A1/fr not_active Abandoned
- 2006-06-16 SG SG201004237-2A patent/SG162798A1/en unknown
- 2006-06-16 EP EP10015393A patent/EP2308467A3/fr not_active Withdrawn
- 2006-06-21 TW TW095122383A patent/TW200800159A/zh unknown
-
2007
- 2007-12-06 IL IL187957A patent/IL187957A0/en unknown
-
2011
- 2011-03-02 US US13/038,623 patent/US20110152360A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2308467A2 (fr) | 2011-04-13 |
CA2611592A1 (fr) | 2006-12-21 |
KR20080030024A (ko) | 2008-04-03 |
EP2308467A3 (fr) | 2011-06-22 |
TW200800159A (en) | 2008-01-01 |
WO2006133510A1 (fr) | 2006-12-21 |
US20110152360A1 (en) | 2011-06-23 |
EP1904052A4 (fr) | 2008-12-10 |
EP2138164A1 (fr) | 2009-12-30 |
EP1904052A1 (fr) | 2008-04-02 |
JP2008543789A (ja) | 2008-12-04 |
US20090118354A1 (en) | 2009-05-07 |
IL187957A0 (en) | 2011-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG162798A1 (en) | Liquid pharmaceutical formulations of docetaxel | |
ZA200801575B (en) | Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily | |
NZ593110A (en) | pteridinone derivatives as MODULATORS OF TOLL-LIKE RECEPTORS | |
ZA200900345B (en) | Preparation of pharmaceutical formulations | |
AU2008347158A8 (en) | Oral pharmaceutical dosage forms | |
MX2010014234A (es) | Compuestos pirazol 436. | |
IL195237A0 (en) | Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same | |
EA200901319A1 (ru) | Композиции для назального введения | |
BR112012002080A2 (pt) | formulações farmacêuticas estáveis altamente concentradas de um anticorpo anti-her2 farmaceuticamente ativo, uso de uma formulação, dispositivo de injeção e kit | |
SI2046298T1 (sl) | Farmacevtska odmerna oblika, ki vsebuje farmacevtsko sprejemljiv solubilizirni sestavek | |
UA115131C2 (uk) | Сполуки боронатного ефіру і його фармацевтичні рецептури | |
ZA200903929B (en) | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor | |
IL193727A0 (en) | Dosage forms for administering combinations of drugs | |
EP1933760A4 (fr) | Compositions et methodes d'administration d'analogues de rapamycine avec du paclitaxel a l'aide de dispositifs medicaux | |
GEP20146098B (en) | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their usage as pde9a modulators | |
EP1624855A4 (fr) | Compositions pharmaceutiques et formes posologiques pour l'administration de medicaments hydrophobes | |
MX346879B (es) | Formulaciones de ketorolaco listas para su uso. | |
RS54438B1 (en) | PHARMACEUTICAL DOSAGE FORM CONTAINING 6`-FLUORO- (N-METHYL-OR N, N-DIMETHYL) - 4-PHENYL-4`, 9`-DIHYDRO-3`H-SPIRO [CYCLOHEXANE-1,1`-PIRANO [3,4, B] INDOL] -4-AMINE | |
UA106636C2 (uk) | Морфолінотіазоли як позитивні алостеричні модулятори альфа 7 | |
IL180031A0 (en) | Stable pharmaceutical formulations of benzimidazole compounds | |
JO2814B1 (en) | Combined antiviral tumor-causing mixture | |
SG158863A1 (en) | Intravenous formulations of pde-5 inhibitors | |
EP2361083A4 (fr) | Composition pour le traitement du tissu épithélial | |
ZA200807348B (en) | Dosage aerosols for the administration of pharmaceutical preparations | |
MX2007015171A (es) | Formulacion que comprende farnesil dibenzodiazepinona y un tensoactivo farmaceuticamente aceptable. |